Clinical Value of Prick Therapy Combined With Wheat Grain Moxibustion in the Treatment of Spleen Deficiency and Dampness Obstructed Cancer
NCT06074718 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2024-05-09
Summary
This study aims to investigate the clinical efficacy and associated immune and inflammatory mechanisms in patients with malignant tumors of spleen deficiency and dampness resistance type, by applying pricking therapy and wheat grain moxibustion on the back shu points or positive reaction points.
Conditions
- Pricking Therapy on the Back Shu Points
- Wheat Grain Moxibustion on the Back Shu Points
Interventions
- OTHER
-
pricking therapy and wheat grain moxibustion
pricking therapy and wheat grain moxibustion on the back shu points or positive reaction points
Sponsors & Collaborators
-
Jiangsu Taizhou People's Hospital
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-02
- Primary Completion
- 2024-09-30
- Completion
- 2024-09-30
Countries
- China
Study Locations
More Related Trials
-
Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma
NCT05602415 ·Status: UNKNOWN ·Phase: PHASE2
-
The Clinical Efficacy and Safety of Intratumoral Injection of Chemotherapy for Advanced Solid Tumors
NCT06430515 ·Status: RECRUITING ·Phase: NA
-
Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPC
NCT06573398 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Broadband Collaborative Pulse Ablation Instrument Treating Malignant Pulmonary Nodules
NCT06530667 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Clinical Study of SPH6516 Tablets in the Treatment of Advanced Solid Tumors.
NCT06266923 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FN
NCT07187908 ·Status: RECRUITING ·Phase: PHASE2
-
SKB264 Monotherapy in Selected Subjects With Advanced Solid Tumors
NCT05631262 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
An Expanded Clinical Study of Triple Therapy for Refractory Solid Tumors That Failed First-line Treatment for Recurrence and Metastasis
NCT05438342 ·Status: UNKNOWN ·Phase: NA
-
A Phase I Study Evaluating SCB-313(Recombinant Human TRAIL-Trimer Fusion Protein) for the Treatment of Malignant Pleural Effusion
NCT04123886 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of SBRT in Combination With rhGM-CSF for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy
NCT02623595 ·Status: WITHDRAWN ·Phase: PHASE2
-
Exploratory Study of Novel MSLN CAR-T Cell Therapy in Patients With MSLN-positive Advanced Refractory Solid Tumors
NCT05531708 ·Status: WITHDRAWN ·Phase: PHASE1
-
JSKN033 in Chinese Subjects with Advanced Malignant Tumors
NCT06770881 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Tislelizumab Combined With Thoracic Radiotherapy as Neoadjuvant Therapy for Resectable NSCLC
NCT07050056 ·Status: RECRUITING ·Phase: PHASE2
-
Curative Study of Chinese Traditional Medicine to Treat Lung Cancer
NCT02777788 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Abscopal Effect of SBRT in Combination With rhGM-CSF and INF-α 2b for Metastatic Thymic Epithelial Tumors
NCT04517539 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase I Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion
NCT05923515 ·Status: UNKNOWN ·Phase: PHASE1
-
Efficacy and Safety of Radiotherapy Combined With Apatinib Mesylate in the Treatment of Rhabdomyosarcoma in Children
NCT03868852 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Multicenter, Real-world Study of Adebrelimab in the Treatment of Extensive Stage Small Cell Lung Cancer
NCT06267170 ·Status: NOT_YET_RECRUITING
-
Electroacupuncture Combined With Paclitaxel Protein-bound and PD-1 Antibody for Second-line Treatment of HER2 Negative, pMMR/MSS Advanced Gastric Cancer
NCT06992024 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human Neutrophils
NCT06240767 ·Status: RECRUITING ·Phase: PHASE1
-
Low Dose Radiotherapy Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Stage II-III NSCLC
NCT06714708 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluating the Clinical Value of Traditional Chinese Medicine in the Adjuvant Therapy of Triple-negative Breast Cancer
NCT04403529 ·Status: UNKNOWN ·Phase: PHASE3
-
High Dose Radiation Therapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung Cancer
NCT03598517 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety Study of Medical Thoracoscope Cryotherapy Combined Standard First-line Treatment of Advanced Non-small Cell Lung Cancer and Malignant Pleural Effusion
NCT05291403 ·Status: UNKNOWN ·Phase: NA
-
A Study of Subcutaneous Delivery of JNJ-54767414 in Chinese Participants With Multiple Myeloma
NCT04121260 ·Status: COMPLETED ·Phase: PHASE1